Abstract
Background:
Postoperative opioid prescriptions may be associated with risks of unintentional poisoning and drug diversion in other household members. The objective of this study was to explore the association between mothers’ postoperative opioid prescriptions and incidence of opioid-related events in their children (aged 1 to 24 years).
Data and methods:
This retrospective cohort study used individually linked administrative health data from Ontario, Canada. A population-based sample of 170,156 opioid-naïve mothers (aged 15 to 64) (see Figure 1) who underwent surgery between 2013 and 2017 in Ontario was linked through birth records to create a cohort of their 283,550 opioid-naïve children (aged 1 to 24). The association between postoperative opioid analgesic prescriptions filled by mothers within seven days of discharge after surgery and opioid-related events (emergency department presentations or inpatient admissions for opioid poisoning, or mental and behavioural disorders attributable to opioid use) in their children within one year of their mother’s discharge was assessed.
Results:
Overall, 60.4% of the children in the cohort had a mother who filled a postoperative opioid prescription. The incidence of opioid-related events in children in the year after a mother’s surgery was low overall (n=36/283,550, 0.01%), but higher among children whose mother filled a postoperative opioid prescription (n=29/171,139, 0.02%, vs. n=7/112,411, 0.01%, p=0.02), including in an analysis adjusting for child’s age, mother’s age, rural residence, neighbourhood income quintile and mother’s Charlson comorbidity index score (adjusted odds ratio, 2.42 [95% confidence interval (CI), 1.05 to 5.54], p=0.04).
Interpretation:
Postoperative opioid prescriptions for mothers may contribute to opioid-related events in their children. These findings further underscore the importance of safe, effective opioid prescribing, as well as of patient and public education about the use, storage and disposal of these medications.
Keywords: surgery, analgesics, opioid, child, adolescent, young adult, prescription drug misuse, drug overdose
In Ontario, in 2017, there were 1,276 emergency department visits for opioid poisoning among people younger than 25. Among those aged 15 to 24, the rate more than doubled between 2013 and 2017.1 Both Canadian and American data suggest that people younger than 25 may be experiencing disproportionate opioid-related harms. This age group makes up roughly 1 in 10 of those who were dispensed an opioid, but accounts for 1 in 5 emergency department presentations for opioid poisoning.2–4 This difference may be related, in part, to illicit opioid use, but evidence also supports another explanation—that some youth access opioids that have been prescribed to others in the household. Survey data from both countries show that, among youth who use opioids, the most common source of these opioids was family or friends.5,6 Two case–control studies (also from Canada and the United States) have shown that opioid prescriptions to family members are associated with an increased risk of hospital-treated overdoses in children7,8 and young adults.8
Postoperative prescriptions are a potentially significant source of opioids. Pain after surgery is one of the most common reasons for initiating opioid use,9,10 but these prescriptions tend to exceed patient need. Therefore, these medications often go unfinished,11 and unused medications are then stored—unsecured—at home.12 A systematic review of studies describing postoperative opioid oversupply found that, across six studies, 67% to 92% of patients reported having unused opioids, and 42% to 71% of opioids went unused.13
The objective of this study was to examine the association between mothers’ postoperative opioid prescriptions and opioid-related emergency department presentations or inpatient admissions by their children (aged 1 to 24 years).
Methods
Study sample
This retrospective cohort used population-based data from Ontario, Canada, which included residents eligible for universal health care coverage (nearly the entire population of roughly 14 million people) and captured inpatient admissions (Discharge Abstract Database [DAD]), same-day surgical procedures (Same Day Surgery [SDS] Database), opioid prescriptions (Narcotics Monitoring System [NMS]), emergency department presentations (National Ambulatory Care Reporting System), deaths (Office of the Registrar General – Deaths) and individual-level demographic information (Registered Persons Database). These datasets were linked using unique encoded identifiers and analyzed at ICES (a not-for-profit research institute formerly known as the Institute for Clinical Evaluative Sciences). The use of data in this project was authorized under section 45 of Ontario’s Personal Health Information Protection Act, which does not require review by a research ethics board.
The cohort was defined using the DAD and SDS surgical records14,15 of females aged 15 to 64 years who had a hospital stay of seven days or less and were discharged home. The accrual period (discharge dates between July 2013 and March 2017) was selected to coincide with the introduction of the NMS in 2012, as well as with the necessary one-year review of these data (see exclusions below). Only one surgical record was retained for each individual. For those with multiple surgeries during the study period, only the first was considered for inclusion. The records of these individuals were then linked to those of their children (aged 1 to 24 years at the time of surgery) using the ICES-derived MOMBABY database, which has linked the inpatient records of delivering mothers and their newborns for births in Ontario since 1988. There are no comparable linkages for fathers or other household members. Young adults—up to age 24—were also included in the cohort, as 62.6% of Canadians aged 20 to 24 still live with their parents, but the proportion declines precipitously thereafter.16 If the same individual appeared in both cohorts, she was excluded from the mother cohort (and all of her children were subsequently removed from the children cohort). Mothers and all of their children were excluded if either had (1) filled any opioid prescription (including for methadone or buprenorphine) within one year prior to the surgery (i.e., to create an opioid-naïve cohort), (2) experienced an opioid-related event17 within one year prior to the surgery (see appendix) or (3) died within one year of the surgery (i.e., to ensure complete follow-up).
Measures
Exposure, i.e., a mother’s postoperative opioid analgesic prescription, was defined as a prescription for oral tablet forms of codeine, fentanyl, hydromorphone, meperidine, morphine, oxycodone, pentazocine, tapentadol or tramadol filled within seven days of the surgery (i.e., on the surgery discharge date or within the six subsequent days). The first prescription filled during these seven postoperative days was defined as the index prescription. If more than one opioid prescription was filled on the first day, all records were retained. The primary outcome was an opioid-related event17 within one year of the mother’s surgery discharge date or index prescription date (as applicable). Opioid-related events included emergency department presentations and inpatient admissions for opioid poisoning, or mental and behavioural disorders resulting from opioid use (see appendix for a list of diagnosis codes). Information on age, sex and residential postal code of the mothers and children at the time of surgery was also retained. Postal codes were used to assign rural residence (community with a population of fewer than 10,000 people) and neighbourhood income quintile.18 Mothers’ Charlson comorbidity scores were determined using data from the index surgical record,19 and their surgeries were categorized by year, as either inpatient or outpatient, and according to the Canadian Classification of Health Interventions.20 Index prescriptions were described according to days’ supply and total morphine milligram equivalent (MME)21 dose and categorized by type (codeine, hydromorphone, morphine, oxycodone, tramadol, other or multiple).
Statistical analysis
Frequencies and proportions (with chi-square tests) means and standard deviations (with t-tests) and medians and interquartile ranges (IQR) were reported to describe characteristics of the mothers and children. The association between mothers’ postoperative opioid prescriptions and the risk of opioid-related events in their children was assessed using logistic regression, first unadjusted, then adjusted for child’s age, mother’s age, rural residence and neighbourhood income quintile—variables selected based on previous findings.1–4,22 Four sensitivity analyses were conducted: (1) to account for the potential clustering of children (by mother), one child was randomly selected per mother; (2) to assess for likely diversion (rather than unintentional poisoning), the analysis was restricted to children aged 12 to 24 years; (3) to acknowledge the unique postoperative context of the first year postpartum (i.e., mother’s new baby or child’s new sibling), children of mothers who underwent a caesarean section were excluded; and, (4) to account for the possibility of opioid-related deaths, the cohort was recreated without applying the final exclusion, and opioid-related deaths were included in the outcome. Statistical significance was interpreted at p<0.05. Analyses were carried out using SAS software, Version 9.4 (SAS Institute, Cary, North Carolina).
Results
Cohort characteristics
After exclusions were applied (see Figure 1), the cohort consisted of 283,550 children (see Table 1) linked to 170,156 mothers (see Table 2). Overall, 60.4% of the children had mothers who filled a postoperative opioid prescription. The children of mothers who filled a prescription were older, had older mothers, and were more likely to live in non-rural areas and higher-income neighbourhoods. The most commonly dispensed opioids were oxycodone, codeine, tramadol and hydromorphone, which together accounted for 92.6% of postoperative opioid prescriptions. The median prescription duration was three days (IQR: 3 to 5 days) and the median total MME was 150.0 (IQR: 112.5 to 225.0).
Figure 1. Selection of a surgical cohort of opioid-naïve mothers (aged 15 to 64 years) and their opioid-naïve children (aged 1 to 24 years), Ontario, Canada, 2013 to 2017 Source:

Authors’ compilation.
Table 1.
Cohort characteristics, opioid-naïve children (aged 1 to 24 years) of opioid-naïve mothers who underwent surgery in Ontario, Canada, July 2013 to March 2017
| Characteristic | Total/overall (11=283,550) | Mother filled postoperative opioid prescription (n=171,139) | Mother did not fill postoperative opioid prescription (n=112,411) | P-value‡ | |||
|---|---|---|---|---|---|---|---|
| mean | Standard deviation | mean | Standard deviation | mean | Standard deviation | p-value‡ | |
| Age, child, years | 10.6 | 6.6 | 11.0 | 6.8 | 10.0 | 6.8 | <0.001 |
| Age, mother, years | 40.2 | 8.3 | 40.7 | 8.2 | 39.4 | 8.4 | <0.001 |
| number | percent | number | percent | number | percent | p-value‡ | |
| Sex, male | 146,951 | 51.8 | 88,505 | 51.7 | 58,446 | 52.0 | 0.15 |
| Residence | |||||||
| Rural | 38,571 | 13.6 | 22,480 | 13.1 | 16,091 | 14.3 | <0.001 |
| Non-rural | 244,979 | 86.4 | 148,659 | 86.9 | 96,320 | 85.7 | N/A |
| Neighbourhood income quintile | |||||||
| First (lowest) | 49,852 | 17.6 | 28,307 | 16.5 | 21,545 | 19.2 | <0.001 |
| Second | 51,700 | 18.2 | 30,502 | 17.8 | 21,198 | 18.9 | N/A |
| Third | 57,094 | 20.1 | 34,490 | 20.2 | 22,604 | 20.1 | N/A |
| Fourth | 64,581 | 22.8 | 39,998 | 23.4 | 24,583 | 21.9 | N/A |
| Fifth (highest) | 57,930 | 20.4 | 36,559 | 21.4 | 21,371 | 19.0 | N/A |
| Missing | 2,393 | 0.8 | 1,283 | 0.7 | 1,110 | 1.0 | N/A |
chi-square (categorical) or t-tests (means)
Note:N/A stands for not applicable (single p-value is reported from chi-square test of cross-tabulated categorical variables).
Sources: 1. Inpatient admissions (Discharge Abstract Database), 2. Same-day surgical procedures (Same Day Surgery Database), 3. Opioid prescriptions (Narcotics Monitoring System), 4. Emergency department presentations (National Ambulatory Care Reporting System), 5. Deaths (Office of the Registrar General – Deaths) and individual-level demographic information (Registered Persons Database), 6. Mother–baby linked database (ICES-derived MOMBABY database).
Table 2.
Cohort characteristics, opioid-naïve mothers who underwent surgery in Ontario, Canada, July 2013 to March 2017
| Characteristic | Total/overall (n=170,156) | Filled postoperative opioid prescription (n=100,521) | Did not fill postoperative opioid prescription (n=69,635) | P-value‡ | |||
|---|---|---|---|---|---|---|---|
| mean | Standard deviation | mean | Standard deviation | mean | Standard deviation | p-value‡ | |
| Age, mother | 40.3 | 8.8 | 40.9 | 8.7 | 39.3 | 8.9 | <0.001 |
| number | percent | number | percent | number | percent | p-value‡ | |
| Number of linked children | |||||||
| 1 | 86,269 | 50.7 | 48,143 | 47.9 | 38,126 | 54.8 | <0.001 |
| 2 | 61,378 | 36.1 | 38,276 | 38.1 | 23,102 | 33.2 | N/A |
| 3 or more | 22,509 | 13.2 | 14,102 | 14.0 | 8,407 | 12.1 | N/A |
| Residence | |||||||
| Rural | 22,113 | 13.0 | 12,738 | 12.7 | 9,375 | 13.5 | <0.001 |
| Non-rural | 148,043 | 87.0 | 87,783 | 87.3 | 60,260 | 86.5 | N/A |
| Neighbourhood income quintile | |||||||
| First (lowest) | 29,300 | 17.2 | 16,322 | 16.2 | 12,978 | 18.6 | <0.001 |
| Second | 31,024 | 18.2 | 17,836 | 17.7 | 13,188 | 18.9 | N/A |
| Third | 34,665 | 20.4 | 20,516 | 20.4 | 14,149 | 20.3 | N/A |
| Fourth | 39,289 | 23.1 | 23,742 | 23.6 | 15,547 | 22.3 | N/A |
| Fifth (highest) | 35,063 | 20.6 | 21,719 | 21.6 | 13,344 | 19.2 | N/A |
| Missing | 815 | 0.5 | 386 | 0.4 | 429 | 0.6 | N/A |
| Surgery | |||||||
| Outpatient | 89,409 | 52.5 | 56,601 | 56.3 | 32,808 | 47.1 | <0.001 |
| Inpatient | 80,747 | 47.5 | 43,920 | 43.7 | 36,827 | 52.9 | N/A |
| Charlson comorbidity index | |||||||
| 0 | 157,284 | 92.4 | 91,357 | 90.9 | 65,927 | 94.7 | <0.001 |
| 1 | 4,100 | 2.4 | 2,603 | 2.6 | 1,497 | 2.1 | N/A |
| 2+ | 8,772 | 5.2 | 6,561 | 6.5 | 2,211 | 3.2 | N/A |
| Intervention | |||||||
| Nervous system | 3,367 | 2.0 | 2,474 | 2.5 | 893 | 1.3 | <0.001 |
| Eye and ocular adnexa | 3,832 | 2.3 | 256 | 0.3 | 3,576 | 5.1 | N/A |
| Ear and mastoid (process) | 956 | 0.6 | 732 | 0.7 | 224 | 0.3 | N/A |
| Orocraniofacial region | 9,767 | 5.7 | 7,505 | 7.5 | 2,262 | 3.2 | N/A |
| Respiratory system | 538 | 0.3 | 352 | 0.4 | 186 | 0.3 | N/A |
| Cardiovascular system | 1,565 | 0.9 | 1,205 | 1.2 | 360 | 0.5 | N/A |
| Lymphatic system | 284 | 0.2 | 203 | 0.2 | 81 | 0.1 | N/A |
| Digestive, hepatobiliary and abdominal | 21,746 | 12.8 | 16,534 | 16.4 | 5,212 | 7.5 | N/A |
| Genitourinary system | 47,839 | 28.1 | 24,524 | 24.4 | 23,315 | 33.5 | N/A |
| Musculoskeletal system | 21,724 | 12.8 | 18,237 | 18.1 | 3,487 | 5.0 | N/A |
| Skin, subcutaneous tissue and breast | 14,723 | 8.7 | 11,432 | 11.4 | 3,291 | 4.7 | N/A |
| Caesarean section delivery | 42,241 | 24.8 | 16,445 | 16.4 | 25,796 | 37.0 | N/A |
| Other | 1,574 | 0.9 | 622 | 0.6 | 952 | 1.4 | N/A |
| Year of surgery | |||||||
| 2013 (July to December) | 25,507 | 15.0 | 14,473 | 14.4 | 11,034 | 15.8 | <0.001 |
| 2014 | 50,540 | 29.7 | 29,431 | 29.3 | 21,109 | 30.3 | N/A |
| 2015 | 44,975 | 26.4 | 26,732 | 26.6 | 18,243 | 26.2 | N/A |
| 2016 | 39,792 | 23.4 | 24,238 | 24.1 | 15,554 | 22.3 | N/A |
| 2017 (January to March) | 9,342 | 5.5 | 5,647 | 5.6 | 3,695 | 5.3 | N/A |
| Index opioid | |||||||
| Type | |||||||
| Codeine | … | … | 34,527 | 34.3 | … | … | … |
| Hydromorphone | … | … | 10,759 | 10.7 | … | … | … |
| Morphine | … | … | 5,419 | 5.4 | … | … | … |
| Oxycodone | … | … | 35,457 | 35.3 | … | … | … |
| Tramadol | … | … | 12,379 | 12.3 | … | … | … |
| Other | … | … | 218 | 0.2 | … | … | … |
| Multiple | … | … | 1,762 | 1.8 | … | … | … |
| Days’ supply | |||||||
| Mean (SD) | … | … | 4.3 | 3.2 | … | … | … |
| Median (IQR) | … | … | 3 | 3–5 | … | … | … |
| Total MME | |||||||
| Mean (SD) | … | … | 184.2 | 129.1 | … | … | … |
| Median (IQR) | … | … | 150.0 | 112.5–225.0 | … | … | … |
… not applicable
chi-square (categorical) or t-tests (means)
Notes:IQR stands for interquartile range, MME stands for morphine milligram equivalent, SD stands for standard deviation and N/A stands for not applicable (single p-value is reported from chi-square test of cross-tabulated categorical variables).
Sources: 1. Inpatient admissions (Discharge Abstract Database), 2. Same-day surgical procedures (Same Day Surgery Database), 3. Opioid prescriptions (Narcotics Monitoring System), 4. Emergency department presentations (National Ambulatory Care Reporting System), 5. Deaths (Office of the Registrar General – Deaths) and individual-level demographic information (Registered Persons Database), 6. Mother–baby linked database (ICES-derived MOMBABY database).
Opioid-related events
Opioid-related events in children in the first year after a mother’s surgery were rare (n=36/283,550, 0.01%). However, the incidence of opioid-related events was higher among the children of mothers who filled a postoperative opioid prescription (n=29/171,139, 0.02% vs. n=7/112,411, 0.01%; unadjusted odds ratio [OR] 2.72 [1.19 to 6.21] p=0.02), including in the adjusted analysis (adjusted OR 2.42 [95% CI, 1.05 to 5.54], p=0.04) (see Table 3). Sensitivity analyses produced similar results, although some associations lost statistical significance (see Table 3). Nevertheless, the unadjusted, adjusted and sensitivity analyses’ odds ratio estimates all fell between 2 and 3. The differences observed were not entirely explained by adjustment variables or clustering (by mother) and also held for specific subpopulations within the cohort.
Table 3.
Association between mothers’ postoperative opioid prescription and opioid-related events in their children aged 1 to 24 years within one year of surgery
| Model | Number with outcome events | Population | Odds ratio | P-value | ||
|---|---|---|---|---|---|---|
| Estimate | 95% confidence interval | |||||
| From | To | |||||
| Crude/unadjusted | 36 | 283,550 | 2.72 | 1.19 | 6.21 | 0.02 |
| Adjusted‡ | 36 | 281,157 | 2.42 | 1.05 | 5.54 | 0.04 |
| Sensitivity analyses | ||||||
| Restricting to one randomly selected child per mother | .. | 170,156 | 2.63 | 0.98 | 7.05 | 0.05 |
| Restricting to children aged 12 to 24 years | .. | 119,856 | 2.12 | 0.92 | 4.87 | 0.08 |
| Restricting to children of mothers whose surgery was not a caesarean section | .. | 225,426 | 2.07 | 0.91 | 4.75 | 0.08 |
| Including children and children of mothers who died within one year of surgery and opioid-related deaths in the outcome | .. | 283,889 | 2.72 | 1.19 | 6.21 | 0.02 |
Adjusted for child’s age, mother’s age, rural residence, neighbourhood income quintile and mother’s Charlson comorbidity index score
Note: Cells containing “..” cannot be reported to minimize re-identification risk (i.e., differences of n<6 between number of events in sensitivity analyses and main analyses).
Sources: 1. Inpatient admissions (Discharge Abstract Database), 2. Same-day surgical procedures (Same Day Surgery Database), 3. Opioid prescriptions (Narcotics Monitoring System), 4. Emergency department presentations (National Ambulatory Care Reporting System), 5. Deaths (Office of the Registrar General – Deaths) and individual-level demographic information (Registered Persons Database), 6. Mother–baby linked database (ICES-derived MOMBABY database).
Discussion
Incidence of opioid-related events in children in the first year after their mother’s surgery was low overall, but comparable to previously published estimates.1 However, the children of mothers who filled a postoperative opioid prescription had an increased risk of an opioid-related event during this time. These results mirror findings from two previous case–control studies that found that the presence of household opioid prescriptions more than doubles the risk of opioid overdose.7,8 However, the focus on surgery identifies a specific context for opioid prescribing and intervention.
Strengths of this study include a large, population-based cohort assembled through a unique mother–child linkage. The results likely generalize to other populations, particularly where the over-prescribing of opioids after surgery appears to be common.23 In particular, beyond the Canadian context, recent data show that comparable proportions of Canadian and American patients are dispensed a postoperative opioid prescription. However, American patients received significantly higher total quantities of opioids,19 suggesting an even greater opportunity for diversion.
However, this study has limitations. First, there was no direct measure of whether children lived with their mother or accessed their mother’s prescription opioids. Second, similar to previously published estimates for this age group and time period,1 opioid-related events were rare. Health administrative data are widely used for researching and reporting opioid-related harms,1–4 but include only those who present to hospital. These data likely underestimate the actual extent of opioid diversion in this population, particularly for older children who may be less likely to present to hospital in the context of opioid use1–6 or self-harm.24 Furthermore, given the infrequency of the outcome, the analyses were not elaborated upon, including to disaggregate events by intent (e.g., self-harm or unintentional poisoning), assess risk according to opioid prescription characteristics (e.g., type of opioid, dose–response relationship or number of refills), analyze trends over time, test hypotheses of mediation or stratify analyses to examine specific subpopulations of mothers and children—all of which merit further research. Still, these data provide some insights into prescription opioid availability for nonmedical use, which is an area that typically relies on survey data and represents a key data gap in addressing public health issues associated with opioid analgesics.25 Third, there may be residual confounding. However, a previous case–control study that assessed the association between opioid prescriptions to family members and opioid overdoses and included a range of covariates reported almost identical unadjusted and adjusted odds ratios.8 Regardless, the potential impact of opioid use in other household members26 could not be assessed with these data.
Opioids are important for managing pain after surgery. However, concerns over the potential negative impacts of excessive opioid prescribing in this context have prompted efforts to reduce these prescriptions, including through interventions implemented at the individual, health care system and policy levels. These findings suggest that postoperative opioid prescriptions may contribute to opioid-related events among others in the household. These results have implications for both clinical practice and future research. First, taken in context with the tendency for postoperative opioid prescriptions to exceed patient need,11–13 these results reinforce the importance of “right-sized” postoperative opioid prescriptions and further highlight the roles of prescribers, dispensers and public health campaigns in educating patients and the public about the safe use, storage and disposal of these medications.27,28 For research purposes, better evidence is needed to establish optimal postoperative opioid prescribing practices and develop interventions to support their implementation.29
What is already known on this subject?
People younger than 25 may be at risk for opioid-related harms related to unintentional poisoning with and diversion of opioids prescribed to someone else in the household.
Postoperative prescriptions are a potentially significant source of opioids in the household, as pain after surgery is one of the most common indications for initiating opioids, and these prescriptions often go unfinished and are then stored—unsecured—at home.
What does this study add?
Postoperative opioid prescriptions for mothers may contribute to opioid-related events in their children.
These findings further underscore the importance of safe, effective opioid prescribing, as well as of patient and public education on the use, storage and disposal of these medications.
Funding statement
This study was funded by the National Institute on Drug Abuse, National Institutes of Health (grant number 1R01DA042299-01A1 to HW, BB, MDN, GL and DNW). This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and do not reflect those of the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this study are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI) and the Ontario Office of the Registrar General (ORG). However, the analyses, conclusions, opinions and statements expressed in this study are those of the authors and not necessarily those of CIHI or ORG. The authors would like to thank IMS Brogan Inc. for the use of its Drug Information Database. Dr. Wunsch is supported by an Excellence in Research Award from the Department of Anesthesia at the University of Toronto. Dr. Wijeysundera is supported in part by a New Investigator Award from the Canadian Institutes of Health Research, an Excellence in Research Award from the Department of Anesthesia at the University of Toronto, and the Endowed Chair in Translational Anesthesiology Research at St. Michael’s Hospital and the University of Toronto.
Appendix
Table A.
Definition of opioid-related event outcome
| ICD-10-CAcode | Description |
|---|---|
| T40.0 | Poisoning by opium |
| T40.1 | Poisoning by heroin |
| T40.2 | Poisoning by other opioids |
| T40.3 | Poisoning by methadone |
| T40.4 | Poisoning by other synthetic narcotics |
| T40.6 | Poisoning by other and unspecified narcotics |
| F11.0 | Mental and behavioural disorders due to use of opioids, acute intoxication |
| F11.1 | Mental and behavioural disorders due to use of opioids, harmful use |
| F11.2 | Mental and behavioural disorders due to use of opioids, dependence syndrome |
| F11.3 | Mental and behavioural disorders due to use of opioids, withdrawal state |
| F11.4 | Mental and behavioural disorders due to use of opioids, withdrawal state with delirium |
| F11.5 | Mental and behavioural disorders due to use of opioids, psychotic disorder |
| F11.6 | Mental and behavioural disorders due to use of opioids, amnesic syndrome |
| F11.7 | Mental and behavioural disorders due to use of opioids, residual and late-onset psychotic disorder |
| F11.8 | Mental and behavioural disorders due to use of opioids, other mental and behavioural disorders |
| F11.9 | Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder |
Notes: Any emergency department presentation (via the National Ambulatory Care Reporting System) or inpatient admission (via the Discharge Abstract Database) record listing any one of the above International Statistical Classification of Diseases and Related Health Problems, 10th revision, Canada (ICD-10-CA), codes as a primary or any other diagnosis.
Source: Authors’ compilation.
References
- 1.Canadian Institute for Health Information. Opioid-related Harms in Canada, December 2018. Available at: https://www.cihi.ca/sites/default/files/document/opioid-related-harms-report-2018-en-web.pdf. Accessed December 16, 2019.
- 2. Gomes T, Pasricha S, Martins D, et al. Behind the Prescriptions: A Snapshot of Opioid Use Across All Ontarians. Available at: https://odprn.ca/wp-content/uploads/2017/08/ODPRN-Report_Behind-the-Prescriptions.pdf. Accessed March 13, 2019.
- 3.Martins D, Greaves S, Tadrous M, et al. Opioid Use and Related Adverse Events in Ontario. Available at: https://odprn.ca/wp-content/uploads/2016/11/ODPRN-Opioid-Use-and-Related-Adverse-Events-Nov-2016.pdf. Accessed March 13, 2019.
- 4.Centers for Disease Control and Prevention. 2018. Annual Surveillance Report of Drug-related Risks and Outcomes — United States. Surveillance Special Report. Available at: https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf. Accessed March 13, 2019. [Google Scholar]
- 5.McCabe SE, Teter CJ, Boyd CJ, et al. Sources of prescription medication misuse among young adults in the United States: The role of educational status. Journal of Clinical Psychiatry 2018; 79(2): 17m11958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Boak A, Hamilton HA, Adlaf EM, Mann RE. Drug Use Among Ontario Students, 1977–2017: Detailed Findings from the Ontario Student Drug Use and Health Survey (OSDUHS). Available at: https://www.camh.ca/-/media/files/pdf---osduhs/mental-health-and-well-being-of-ontario-students-1991-2017---detailed-osduhs-findings-pdf.pdf. Accessed March 25, 2019.
- 7.Finkelstein Y, Macdonald EM, Gonzalez A, et al. Overdose risk in young children of women prescribed opioids. Pediatrics 2017; 139(3): e20162887. [DOI] [PubMed] [Google Scholar]
- 8.Khan NF, Bateman BT, Landon JE, Gagne JJ. Association of opioid overdose with opioid prescriptions to family members. JAMA Internal Medicine 2019; 179(9): 1186–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pasricha SV, Tadrous M, Khuu W, et al. Clinical indications associated with opioid initiation for pain management in Ontario, Canada: A population-based cohort study. Pain 2018; 159(8): 1562–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shah A, Hayes CJ, Martin BC. Factors influencing long-term opioid use among opioid naive patients: An examination of initial prescription characteristics and pain etiologies. The Journal of Pain 2017; 18(11): 1374–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fujii MH, Hodges AC, Russell RL, et al. Post-discharge opioid prescribing and use after common surgical procedure. Journal of the American College of Surgeons 2018; 226(6): 1004–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bartels K, Mayes LM, Dingmann C, et al. Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One 2016; 11(1): e0147972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bicket MC, Long JJ, Pronovost PJ, et al. Prescription opioid analgesics commonly unused after surgery: A systematic review. JAMA Surgery 2017; 152(11): 1066–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Urbach DR, Govindarajan A, Saskin R, et al. Introduction of surgical safety checklists in Ontario, Canada. New England Journal of Medicine 2014; 370(11): 1029–38. [DOI] [PubMed] [Google Scholar]
- 15.Brown HK, Kirkham YA, Cobigo V, et al. Labour and delivery interventions in women with intellectual and developmental disabilities: A population-based cohort study. Journal of Epidemiology and Community Health 2016; 70(3): 238–44. [DOI] [PubMed] [Google Scholar]
- 16.Canada Statistics. Young adults living with their parents in Canada in 2016. Census in Brief. Available at: https://www12.statcan.gc.ca/census-recensement/2016/as-sa/98-200-x/2016008/98-200-x2016008-eng.cfm. Accessed August 27, 2019. [Google Scholar]
- 17.Moe J, Camargo CA, Jelinski S, et al. Epidemiologic trends in substance and opioid misuse-related emergency department visits in Alberta: A cross-sectional time-series analysis. Canadian Journal of Public Health 2018; 109(2): 164–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wilkins R PCCF + Version 5E User’s Guide. Available at: http://publications.gc.ca/collections/collection_2018/statcan/CS82-0086-2009-1-eng.pdf. Accessed March 5, 2019.
- 19.Ladha KS, Neuman MD, Broms G, et al. Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Network Open 2019; 2(9): e1910734.31483475 [Google Scholar]
- 20.Canadian Institute for Health Information. Canadian Classification of Health Interventions. Available at: https://www.cihi.ca/en/cci_volume_three_2012_en.pdf. Accessed November 8, 2018.
- 21.Centers for Medicare & Medicaid Services. Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors. Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-Conversion-Factors-Aug-2017.pdf. Accessed June 5, 2018.
- 22.Cairncross ZF, Herring J, van Ingen T, et al. Relation between opioid-related harms and socioeconomic inequalities in Ontario: A population-based descriptive study. CMAJ Open 2018; 6(4): E478–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. The Lancet 2019; 13(393): 1547–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Madge N, Hewitt A, Hawton K, et al. Deliberate self-harm within an international community sample of young people: Comparative findings from the Child & Adolescent Self-harm in Europe (CASE) Study. Journal of Child Psychology and Psychiatry 2008; 49(6): 667–77. [DOI] [PubMed] [Google Scholar]
- 25.Schmidt TD, Haddox JD, Nielsen AE, et al. Key data gaps regarding the public health issues associated with opioid analgesics. The Journal of Behavioral Health Services & Research 2015; 42(4): 540–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Seamans MJ, Carey TS, Westreich DJ, et al. Association of household opioid availability and prescription opioid initiation among household members. JAMA Internal Medicine 2018; 178(1): 102–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Abbasi J Emergency department opioid misuse diagnoses increasing in adolescents and young adults. JAMA 2017; 318(24): 2416–7. [DOI] [PubMed] [Google Scholar]
- 28.Binswanger IA, Glanz JM. Pharmaceutical opioids in the home and youth: Implications for adult medical practice. Substance Abuse 2015; 36(2): 141–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wetzel M, Hockenberry J, Raval MV. Interventions for postsurgical opioid prescribing: A systematic review. JAMA Surgery 2018; 153(10): 948–54. [DOI] [PubMed] [Google Scholar]
